Key result
This review highlights how the evolutionary properties of RNA and DNA viruses can be leveraged to develop host-oriented antiviral therapies and immunotherapies.
Why the study?
Pathogen resistance and development costs are major challenges in current approaches to antiviral therapy.
Host-oriented approaches leveraging host-virus co-evolution offer promising biotechnological solutions for antiviral therapy and immunotherapy.
Answers are grounded in this paper and cite their sources.
Supports host-oriented antiviral strategies; leaves open clinical translation pending prospective validation.
Pathogen resistance and development costs are major challenges in current approaches to antiviral therapy. The high error rate of RNA synthesis and reverse-transcription confers genome plasticity, enabling the remarkable adaptability of RNA viruses to antiviral intervention. However, this property is coupled to fundamental constraints including limits on the size of information available to manipulate complex hosts into supporting viral replication. Accordingly, RNA viruses employ various means to extract maximum utility from their informationally limited genomes that, correspondingly, may be leveraged for effective host-oriented therapies. Host-oriented approaches are becoming increasingly feasible because of increased availability of bioactive compounds and recent advances in immunotherapy and precision medicine, particularly genome editing, targeted delivery methods and RNAi. In turn, one driving force behind these innovations is the increasingly detailed understanding of evolutionarily diverse host-virus interactions, which is the key concern of an emerging field, neo-virology. This review examines biotechnological solutions to disease and other sustainability issues of our time that leverage the properties of RNA and DNA viruses as developed through co-evolution with their hosts.
No takes yet. Share an insight, caveat, or question.
Steven M. Heaton (2019) conducted a review in Viral infections. Host-oriented therapies and immunotherapy was evaluated. This review highlights how the evolutionary properties of RNA and DNA viruses can be leveraged to develop host-oriented antiviral therapies and immunotherapies.
Synapse has enriched 10 related papers. Consider them for comparative context: